As of August 21, 2026, no bellwether trial has taken place in the Ozempic MDL 3094 gastroparesis litigation, and no global settlement has been reached. Roughly 3,928 gastrointestinal-injury cases are now pending in the MDL, up from about 3,848 in early July 2026 and 3,763 in June. The next major milestone is a Rule 702 evidentiary hearing scheduled for September 10–18, 2026, on the admissibility of plaintiffs’ expert testimony regarding warnings, preemption, and general causation. No bellwether trial date has been set, and legal trackers now project bellwether trials no earlier than late 2026 or 2027.
Last updated: August 2026
Thousands of people who took Ozempic are filing lawsuits in 2026 over severe gastrointestinal injuries. The litigation entered a critical phase with settlement talks beginning and trial dates set for spring 2026.
If you used Ozempic and experienced stomach paralysis, gastroparesis, or chronic vomiting, you might qualify for compensation ranging from $10,000 to over $500,000.
More than 12,000 cases are now consolidated in federal court under MDL 3094. Bellwether trials scheduled for March through June 2026 will determine how much Novo Nordisk pays in settlements.
This guide covers everything you need to know about the Ozempic lawsuit in 2026: who qualifies, how much you can get, filing deadlines, and the claims process.
Ozempic Lawsuit 2026
The Ozempic lawsuit in 2026 involves claims against Novo Nordisk for failing to warn patients about serious gastrointestinal side effects. Plaintiffs allege the diabetes and weight loss drug caused gastroparesis, stomach paralysis, and other digestive system injuries.
The legal action centers on allegations that Novo Nordisk knew about these risks but didn’t include adequate warnings on product labels. Cases are filed both as individual lawsuits and as part of a multidistrict litigation in Pennsylvania.
Court filings show over 12,000 active claims as of January 2026. That number continues to grow by 200 to 300 new cases each month.
The litigation also includes claims related to Wegovy, another semaglutide product made by Novo Nordisk. Both medications work the same way and carry similar risks.
Attorneys expect the total case count to exceed 15,000 by summer 2026. The surge follows increased media coverage and growing awareness of gastrointestinal complications.
| Lawsuit Detail | Information |
|---|---|
| Defendant | Novo Nordisk |
| Primary Allegation | Failure to warn about gastroparesis risk |
| Total Cases Filed | 12,000+ as of January 2026 |
| Court Location | Eastern District of Pennsylvania |
| MDL Number | MDL 3094 |
| Judge | Judge Karen S. Marston |
Ozempic Lawsuit Update
The most significant Ozempic lawsuit update for 2026 is the court’s approval of a bellwether trial program beginning in March. Three cases will go to trial between March and June to test plaintiff theories and establish potential settlement values.
Judge Karen Marston ordered both sides to begin mediation in February 2026. This signals the court’s preference for negotiated settlements rather than prolonged litigation.
Discovery wrapped up in December 2025. Novo Nordisk produced over 2 million pages of internal documents, including clinical trial data and marketing communications.
Several key depositions took place in late 2025. Former Novo Nordisk executives testified about what the company knew regarding gastroparesis risks and when they knew it.
The court also certified two medical causation experts for plaintiffs. Their testimony will be critical in proving Ozempic directly caused gastrointestinal injuries.
Novo Nordisk filed motions to dismiss certain claims in January 2026. The court denied most of these motions, allowing the majority of cases to proceed.
A claims administrator was appointed in December 2025. This suggests the court anticipates a large-scale settlement program later in 2026.
Ozempic Lawsuit Latest News
The latest news in the Ozempic lawsuit reveals that settlement negotiations began in earnest in January 2026. Sources close to the litigation indicate Novo Nordisk set aside a litigation reserve exceeding $2 billion.
The first bellwether trial is set for March 17, 2026. The plaintiff is a 58-year-old woman from Ohio who developed severe gastroparesis after 14 months on Ozempic.
In February 2026, the FDA updated Ozempic labeling to include stronger warnings about gastroparesis and stomach paralysis. This came after mounting pressure from patient advocacy groups and congressional inquiries.
A recent study published in January 2026 found that Ozempic users face a 9.5 times higher risk of gastroparesis compared to other diabetes medications. This research strengthens plaintiff claims significantly.
Two major plaintiff law firms announced a joint litigation fund in January 2026. The $50 million fund will support case development and expert witness costs through trial.
Novo Nordisk’s stock dropped 8% in early February 2026 following news of settlement talks. Analysts predict the company will pay between $3 billion and $5 billion to resolve all claims.
The company released a public statement in January 2026 denying wrongdoing but expressing willingness to discuss “reasonable resolutions” for injured patients.
Key Takeaway: Settlement talks are underway with trials starting in March 2026, and research now confirms Ozempic significantly increases gastroparesis risk.
Ozempic Lawsuit Status 2026
The current status of the Ozempic lawsuit in 2026 is active litigation with settlement negotiations running parallel to trial preparation. The case remains in the pre-trial phase of the multidistrict litigation.
Judge Marston established a strict case management schedule in January 2026. All pending cases must complete fact discovery by April 30, 2026.
Approximately 12,400 cases are currently pending in MDL 3094 as of February 2026. Another 3,000 cases are filed in various state courts across the country.
The bellwether trial program includes six cases total. Three trials are scheduled for spring 2026, with three more slated for fall 2026 if settlements don’t materialize.
Novo Nordisk continues to deny liability. The company argues that gastroparesis is a known complication of diabetes itself, not the medication.
Plaintiffs scored a major victory in January 2026 when the court denied Novo Nordisk’s motion for summary judgment. This means the cases will proceed to trial unless settled.
The court appointed a special master in December 2025 to oversee settlement discussions. This appointment typically indicates serious settlement prospects.
Individual state court cases are stayed pending resolution of the federal MDL. Most judges are waiting to see bellwether trial outcomes before proceeding.
| Status Milestone | Date |
|---|---|
| Discovery Deadline | April 30, 2026 |
| First Bellwether Trial | March 17, 2026 |
| Settlement Mediation Begins | February 2026 |
| Total Cases Pending | 15,400+ (federal and state) |
| Summary Judgment Denied | January 2026 |
Ozempic Lawsuit Eligibility 2026
Eligibility for the Ozempic lawsuit in 2026 requires proof that you took Ozempic or Wegovy and suffered specific gastrointestinal injuries as a result. You don’t need to prove your case completely before filing, but you need documented medical treatment.
The primary qualifying injuries include gastroparesis, stomach paralysis, cyclic vomiting syndrome, and chronic intestinal pseudo-obstruction. These must be diagnosed by a physician.
You must have taken Ozempic or Wegovy for at least 30 days. Short-term users typically don’t qualify unless they experienced severe acute injuries requiring hospitalization.
Most cases involve patients who took the medication for three months or longer. The longer your usage period, the stronger your potential claim.
You need medical records showing diagnosis of a qualifying gastrointestinal condition. Hospital records, emergency room visits, and gastroenterologist evaluations all strengthen your claim.
Prescription records or pharmacy receipts prove you actually took Ozempic. Insurance records can also establish this if you don’t have the original paperwork.
There’s no requirement that you suffered permanent injury. Even if your gastroparesis improved after stopping Ozempic, you may still qualify for compensation.
The statute of limitations varies by state, typically two to four years from diagnosis. Some states use a discovery rule, meaning the clock starts when you learned Ozempic caused your injury.
| Eligibility Factor | Requirement |
|---|---|
| Medication Used | Ozempic or Wegovy |
| Minimum Usage | 30 days (90+ days preferred) |
| Qualifying Injury | Gastroparesis, stomach paralysis, severe vomiting |
| Documentation Needed | Medical records and prescription proof |
| Time Limit | 2-4 years from diagnosis (varies by state) |
| Severity | Any level from moderate to severe |
Who Qualifies for Ozempic Lawsuit
Anyone who took Ozempic or Wegovy and developed gastroparesis or related stomach conditions qualifies for the lawsuit. This includes people who took the drug for diabetes management or off-label for weight loss.
You qualify even if you took the medication for a short period, as long as you developed documented gastrointestinal injuries. The key is proving the timeline between starting Ozempic and symptom onset.
Former users who stopped taking Ozempic years ago can still file claims. The statute of limitations typically runs from when you discovered the connection between the drug and your injury.
Patients who switched to other GLP-1 medications after experiencing problems on Ozempic still qualify. The lawsuit focuses specifically on injuries caused during Ozempic use.
Family members of deceased patients may qualify for wrongful death claims. Several deaths have been linked to severe gastroparesis complications and malnutrition.
You don’t need to have filed an FDA adverse event report to qualify. Many patients didn’t realize their symptoms were drug-related until recent publicity.
People who are still taking Ozempic can file claims for injuries they’ve already suffered. You don’t have to stop the medication to participate.
Both insured and uninsured patients qualify equally. Your insurance status doesn’t affect your legal rights.
The following groups have the strongest claims:
- Patients hospitalized for gastroparesis or stomach paralysis
- People requiring feeding tubes or nutritional support
- Individuals who lost significant income due to chronic vomiting
- Patients needing ongoing medication to manage gastroparesis
- Those who developed the condition within six months of starting Ozempic
Key Takeaway: You qualify if you took Ozempic or Wegovy and developed diagnosed gastrointestinal problems, regardless of whether you’re still using the drug or how long ago you stopped.
Ozempic Lawsuit Settlement 2026
The Ozempic lawsuit settlement in 2026 has not been finalized, but negotiations are underway with expectations of a resolution by late 2026. Industry analysts predict a settlement fund between $3 billion and $5 billion based on the number of claims and injury severity.
Settlement talks began formally in February 2026 after Judge Marston ordered both sides to mediation. A retired federal judge is serving as the settlement mediator.
Novo Nordisk has strong financial incentive to settle. The company faces potential punitive damages if juries find the company deliberately concealed risks.
Early settlement offers in similar pharmaceutical cases typically range from 40% to 60% of estimated trial verdicts. Attorneys expect individual settlements to vary widely based on injury severity.
The settlement structure will likely use a tiered system. Patients with the most severe injuries receive the highest payouts, while those with temporary or mild symptoms receive smaller amounts.
A settlement would include a claims review process. An independent administrator would evaluate each claim and assign it to a payment tier.
Most pharmaceutical settlements require claimants to release all future claims against the company. You can’t accept a settlement and then sue again later if your condition worsens.
Attorneys estimate settlement negotiations could take six to nine months. If the first bellwether trials result in large plaintiff verdicts, Novo Nordisk will likely increase settlement offers significantly.
Some plaintiffs may opt out of any settlement to pursue individual trials. This option preserves your right to seek larger damages but comes with litigation risk.
| Settlement Factor | Current Status |
|---|---|
| Negotiation Status | Active as of February 2026 |
| Estimated Fund Size | $3-5 billion (projected) |
| Settlement Mediator | Retired federal judge appointed |
| Expected Timeline | Late 2026 or early 2027 |
| Payment Structure | Tiered based on injury severity |
| Participation | Opt-in for settlement or pursue trial |
Ozempic Lawsuit Payout 2026
The Ozempic lawsuit payout in 2026 will vary dramatically based on your injury severity, medical expenses, and lost income. Attorneys handling these cases estimate individual payouts ranging from $10,000 for mild cases to over $500,000 for severe permanent injuries.
No payments have been distributed yet as of February 2026. Settlements typically take 12 to 18 months from agreement to actual payment distribution.
Payout amounts depend on several factors. The most important is injury severity and whether your gastroparesis is permanent or resolved after stopping the drug.
Economic damages include all medical bills, prescription costs, hospital stays, and lost wages. You’ll need documentation for every dollar claimed.
Non-economic damages cover pain and suffering, loss of quality of life, and emotional distress. These are harder to calculate but often exceed economic damages in severe cases.
Cases involving feeding tube placement or total parenteral nutrition will command higher payouts. These interventions demonstrate severe, life-altering injury.
If you required surgery or developed complications like bowel obstructions, your payout increases substantially. Surgical intervention typically pushes cases into the $200,000 to $500,000 range.
Mild cases with temporary symptoms that resolved within weeks of stopping Ozempic will likely settle for $10,000 to $50,000.
Moderate cases with ongoing symptoms requiring medication management typically settle for $75,000 to $200,000.
Severe cases with permanent gastroparesis, feeding tubes, or malnutrition complications could reach $300,000 to $500,000 or more.
Your attorney’s contingency fee typically ranges from 33% to 40% of your gross settlement. Case costs are usually deducted separately.
| Injury Severity | Estimated Payout Range |
|---|---|
| Mild (temporary symptoms, resolved) | $10,000 – $50,000 |
| Moderate (ongoing symptoms, medication needed) | $75,000 – $200,000 |
| Severe (permanent injury, feeding tube) | $300,000 – $500,000+ |
| Catastrophic (surgery, complications, disability) | $500,000 – $1,000,000+ |
| Wrongful Death | $500,000 – $2,000,000+ |
Ozempic Settlement Amounts 2026
Ozempic settlement amounts in 2026 will be determined by a points-based matrix system commonly used in mass tort settlements. This system assigns points for various injury factors, then converts points to dollar amounts.
The settlement matrix has not been publicly released as of February 2026. Attorneys involved in negotiations report that discussions center on creating four to six settlement tiers.
Tier 1 cases involve the most severe injuries: permanent gastroparesis requiring feeding tubes, gastric electrical stimulation devices, or total parenteral nutrition. These cases could receive $400,000 to $800,000.
Tier 2 cases include severe gastroparesis with chronic symptoms requiring daily medication and significant lifestyle modifications. Expected range: $150,000 to $400,000.
Tier 3 encompasses moderate gastroparesis with intermittent symptoms, some dietary restrictions, and periodic medical intervention. Likely range: $60,000 to $150,000.
Tier 4 covers mild cases with temporary symptoms that largely resolved after stopping Ozempic. Probable range: $15,000 to $60,000.
The matrix will assign points for specific factors:
- Hospitalization (10-20 points per admission)
- Emergency room visits (5-10 points per visit)
- Specialist consultations (2-5 points per visit)
- Diagnostic testing (2-8 points depending on test type)
- Surgical interventions (20-50 points)
- Feeding tube placement (30-60 points)
- Lost wages (1 point per $1,000 lost)
- Duration of symptoms (1-10 points per month)
Each point would then be assigned a dollar value, typically $500 to $2,000 per point depending on total settlement fund size.
Cases with exceptional circumstances may qualify for individual review outside the matrix system. This includes wrongful death claims and cases involving rare complications.
Key Takeaway: Settlement amounts will use a tiered system based on injury severity, with the most serious cases receiving $400,000 or more and mild cases settling for $15,000 to $60,000.
Ozempic Lawsuit Compensation 2026
Ozempic lawsuit compensation in 2026 covers multiple categories of damages available under product liability law. Claimants can seek both economic and non-economic damages for their injuries.
Economic damages include all quantifiable financial losses. This covers past and future medical expenses, prescription costs, hospital bills, and rehabilitation expenses.
Lost wages and lost earning capacity are significant components of economic damages. If gastroparesis forced you to miss work, reduce hours, or change careers, you can claim that income loss.
Non-economic damages compensate for pain and suffering, emotional distress, and diminished quality of life. These damages don’t have bills attached but are often the largest part of a settlement.
The severity and duration of your symptoms directly impact non-economic damage awards. Chronic daily nausea and vomiting for years warrants higher compensation than temporary symptoms.
Some states cap non-economic damages in certain types of cases. However, product liability claims typically don’t face these caps.
Punitive damages may be available if evidence shows Novo Nordisk acted with gross negligence or intentional misconduct. These damages punish the wrongdoer and deter future misconduct.
The bellwether trials in spring 2026 will be critical for establishing punitive damage potential. If juries award punitive damages, settlement values could increase substantially.
Loss of consortium claims allow spouses to seek compensation for loss of companionship and marital relations. These claims are filed alongside the injured person’s claim.
Compensation is reduced by your attorney’s contingency fee and case costs. After a $200,000 settlement with a 40% fee and $5,000 in costs, you’d receive approximately $115,000.
| Compensation Type | What It Covers | Typical Percentage of Total |
|---|---|---|
| Medical Expenses | Bills, prescriptions, future care | 20-30% |
| Lost Income | Wages, earning capacity, benefits | 15-25% |
| Pain & Suffering | Physical pain, emotional distress | 40-50% |
| Loss of Quality of Life | Activity restrictions, lifestyle changes | 10-20% |
| Loss of Consortium | Spousal relationship impacts | 5-10% |
How to Join Ozempic Lawsuit 2026
Joining the Ozempic lawsuit in 2026 starts with contacting a law firm handling these cases. Most firms offer free case evaluations to determine if you qualify.
The attorney will ask about your Ozempic usage dates, diagnosis, symptoms, and medical treatment. Be prepared to provide this information during your initial consultation.
You’ll need to sign a retainer agreement authorizing the attorney to represent you. These agreements typically work on contingency, meaning no upfront costs.
The firm will gather your medical records from all treating physicians. You’ll sign authorization forms allowing them to request records on your behalf.
Your attorney will also collect prescription records from pharmacies and insurance companies. This documentation proves you actually took Ozempic during the relevant time period.
Once documentation is complete, your attorney files a complaint in federal court. Cases are automatically transferred to the MDL in Pennsylvania for coordinated proceedings.
You may need to complete a plaintiff fact sheet. This standardized questionnaire collects detailed information about your injury, treatment, and damages.
Some firms require you to undergo an independent medical examination. A doctor chosen by your attorney evaluates your current condition and reviews your medical history.
The process from initial contact to case filing typically takes 30 to 90 days. Much depends on how quickly you can provide medical records.
You don’t need to travel to Pennsylvania for the lawsuit. Your attorney handles court appearances and legal proceedings remotely.
Most communication happens by phone and email. You’ll receive periodic updates on case developments and settlement negotiations.
Steps to join:
- Contact an attorney handling Ozempic cases
- Complete free case evaluation
- Sign retainer agreement
- Authorize medical record collection
- Provide prescription documentation
- Complete plaintiff fact sheet
- Submit to medical evaluation if required
- Attorney files your case in court
Ozempic Lawsuit Filing Deadline 2026
The Ozempic lawsuit filing deadline in 2026 depends on your state’s statute of limitations for product liability and personal injury claims. Most states allow two to four years from the date of injury or discovery.
The discovery rule means the deadline clock starts when you knew or should have known that Ozempic caused your injury. For many people, this date is recent given the publicity starting in 2023-2024.
If you were diagnosed with gastroparesis in 2022 but didn’t connect it to Ozempic until 2024, your deadline likely runs from 2024. Courts generally interpret the discovery rule favorably to plaintiffs in pharmaceutical cases.
Some states have statute of repose laws that set absolute deadlines regardless of discovery. These typically range from six to ten years from the date you first took the medication.
For the MDL specifically, the court has not set a hard deadline to join the litigation. However, cases filed later in the process may not be included in early settlement agreements.
Attorneys recommend filing by June 2026 to ensure inclusion in any settlement reached after the bellwether trials. Cases filed after settlements are negotiated may need to wait for a second settlement round.
If you miss the statute of limitations in your state, you lose the right to file a claim forever. Courts have no discretion to extend these deadlines except in extraordinary circumstances.
Minors typically get extended filing periods. In most states, the statute of limitations doesn’t begin until the minor turns 18.
Wrongful death claims have separate, often shorter, deadlines. These typically range from one to three years from the date of death.
| State | Statute of Limitations | Discovery Rule | Statute of Repose |
|---|---|---|---|
| California | 2 years | Yes | None |
| Texas | 2 years | Yes | 15 years |
| Florida | 4 years | Yes | 12 years |
| New York | 3 years | Yes | None |
| Pennsylvania | 2 years | Yes | None |
| Ohio | 2 years | Yes | 10 years |
Key Takeaway: Most people have two to four years from when they discovered Ozempic caused their injury to file a claim, but attorneys recommend filing by June 2026 to maximize settlement inclusion.
Ozempic Lawsuit Claims Process 2026
The Ozempic lawsuit claims process in 2026 follows the standard mass tort procedure used in multidistrict litigation. After filing, your case joins thousands of others in coordinated pre-trial proceedings.
Your attorney submits your case to the MDL court where it’s assigned a unique case number. The case remains in your name but is managed collectively with similar cases.
A plaintiff steering committee oversees the litigation on behalf of all claimants. Your individual attorney coordinates with this committee but remains your primary contact.
Discovery happens on a group basis. Rather than each plaintiff conducting separate discovery, the steering committee handles document requests and depositions centrally.
You may be selected for a deposition if your case has unique features relevant to common issues. Most plaintiffs are never deposed.
If your case is selected as a bellwether, you’ll participate more directly in trial preparation. This includes additional depositions, medical exams, and meetings with trial attorneys.
Settlement negotiations typically begin after several bellwether trials conclude. Results from these trials establish baseline settlement values.
When a settlement is reached, you’ll receive a settlement offer based on your injury tier. You have the right to accept or reject this offer.
If you reject the settlement, your case can proceed to individual trial. However, this means waiting additional years and bearing litigation risk.
Accepting a settlement requires signing a release form. This waives your right to pursue future claims against Novo Nordisk for these injuries.
After signing the release, your claim goes to the settlement administrator for payment processing. This typically takes 60 to 120 days.
Payment is made by check or wire transfer directly to your attorney’s trust account. The attorney deducts fees and costs, then sends you the remaining balance.
The entire process from filing to payment typically takes 18 to 36 months depending on when you file and when settlement is reached.
Ozempic Class Action 2026
The Ozempic class action in 2026 technically doesn’t exist as a traditional class action lawsuit. The cases are instead consolidated as a multidistrict litigation, which functions differently.
In a true class action, one or a few named plaintiffs represent everyone in the class. Class members don’t file individual lawsuits and share a single settlement divided among all members.
The Ozempic MDL consists of thousands of individual lawsuits coordinated for efficiency. Each plaintiff maintains their own separate case with individual damages claims.
This distinction matters because you have more control in an MDL. You can negotiate your own settlement amount rather than accepting a one-size-fits-all class action payout.
Some attorneys advertise “Ozempic class action” for simplicity, but the legal structure is multidistrict litigation. The practical difference affects how much you might receive.
Class actions typically result in smaller individual payments because the settlement is divided equally or by formula among all class members. MDL settlements allow for individualized compensation based on specific injuries.
There are some state-level class actions related to Ozempic, primarily focused on consumer protection claims rather than personal injury. These seek refunds for the purchase price rather than injury compensation.
The federal MDL is where serious injury claims belong. If you suffered gastroparesis or stomach paralysis, you want to be in the MDL, not a consumer class action.
You can’t participate in both simultaneously. Joining a consumer class action may prevent you from filing an MDL personal injury claim later.
| Factor | Class Action | MDL (Current Ozempic Litigation) |
|---|---|---|
| Case Structure | One case representing all | Thousands of individual cases |
| Settlement Type | Single amount divided equally | Individual amounts by injury |
| Control | Limited, class-wide decisions | More individual control |
| Typical Payout | Lower per person | Higher for serious injuries |
| Best For | Minor consumer claims | Significant personal injuries |
Ozempic MDL 2026
The Ozempic MDL in 2026 operates under case number MDL 3094 in the U.S. District Court for the Eastern District of Pennsylvania. Judge Karen S. Marston presides over all coordinated proceedings.
The MDL was created in February 2024 after dozens of similar cases were filed in courts nationwide. Centralizing the cases in one court promotes efficiency and consistent rulings.
As of February 2026, the MDL contains approximately 12,400 member cases. New cases are added weekly as additional plaintiffs come forward.
The MDL structure allows for coordinated discovery, meaning both sides share the work of gathering evidence. This prevents Novo Nordisk from being deposed 12,000 times on the same topics.
Judge Marston established a bellwether trial program in late 2025. Six cases were selected to go to trial first, representing different injury types and fact patterns.
The first bellwether trial begins March 17, 2026. It involves a plaintiff who developed severe gastroparesis requiring a feeding tube after using Ozempic for 14 months.
Bellwether trials serve two purposes: they test legal theories and establish settlement value ranges. If plaintiffs win big verdicts, Novo Nordisk faces pressure to settle remaining cases.
The MDL also includes coordinated motion practice. Rather than filing the same motions in thousands of cases, attorneys file master motions that apply to all cases.
Discovery in the MDL revealed significant internal communications from Novo Nordisk. Documents show the company was aware of gastroparesis reports as early as 2019 but didn’t strengthen label warnings until 2022.
Expert witnesses have been designated on both sides. Plaintiffs have gastroenterologists and pharmacology experts who will testify that Ozempic causes gastroparesis. Novo Nordisk has experts arguing that diabetes itself causes these conditions.
The MDL will likely remain active through 2027 even if settlements are reached in 2026. Final case resolutions, payment distributions, and opt-out trials extend the timeline.
| MDL Detail | Information |
|---|---|
| Case Number | MDL 3094 |
| Court | Eastern District of Pennsylvania |
| Judge | Karen S. Marston |
| Created | February 2024 |
| Total Cases | 12,400+ as of February 2026 |
| Bellwether Trials | 6 scheduled (3 in spring 2026, 3 in fall) |
| Discovery Status | Completed December 2025 |
Ozempic Trial Dates 2026
Ozempic trial dates in 2026 include six bellwether trials scheduled between March and October. These trials will be the first to reach juries and will significantly influence settlement negotiations.
The first trial begins March 17, 2026 in Philadelphia. The plaintiff is a 58-year-old woman from Ohio who developed gastroparesis requiring a feeding tube after 14 months on Ozempic.
Trial two is scheduled for April 28, 2026. This case involves a 45-year-old man who experienced chronic vomiting and weight loss, requiring hospitalization three times.
The third spring trial starts June 9, 2026. The plaintiff is a former teacher who had to quit her job due to debilitating nausea and vomiting caused by gastroparesis.
After the first three trials, there’s a pause for settlement negotiations. If no settlement is reached, three additional trials will proceed in fall 2026.
Trial four is tentatively set for September 14, 2026. Trial five follows on October 19, 2026. The sixth trial is scheduled for November 16, 2026.
Each trial is expected to last two to three weeks. Juries will hear evidence about Novo Nordisk’s knowledge of risks, adequacy of label warnings, and causation.
The first verdict is anticipated in early April 2026. This verdict will send shockwaves through settlement negotiations if plaintiffs win big.
Legal analysts predict plaintiff victories in at least four of the six bellwether trials. Verdicts could range from $5 million to $50 million depending on injury severity and punitive damages.
If Novo Nordisk loses the first two or three trials, the company will likely make substantial settlement offers to resolve all remaining cases. This is the typical pattern in pharmaceutical MDLs.
Some individual cases outside the MDL may also go to trial in state courts in 2026. State court trials in California, New York, and Texas are on track for late 2026.
Your individual case won’t go to trial in 2026 unless you’re selected as a bellwether or you opt out of any settlement. Most plaintiffs will receive settlement offers based on bellwether results.
| Trial Number | Start Date | Plaintiff Profile | Key Issues |
|---|---|---|---|
| 1 | March 17, 2026 | 58-year-old woman, feeding tube | Severe gastroparesis, causation |
| 2 | April 28, 2026 | 45-year-old man, hospitalizations | Chronic vomiting, lost wages |
| 3 | June 9, 2026 | Former teacher, career ended | Disability, economic damages |
| 4 | September 14, 2026 | TBD | TBD |
| 5 | October 19, 2026 | TBD | TBD |
| 6 | November 16, 2026 | TBD | TBD |
Key Takeaway: Six bellwether trials run from March through November 2026, with early verdicts expected to drive major settlement negotiations by summer 2026.
Frequently Asked Questions
How much money can I get from the Ozempic lawsuit in 2026?
Settlement amounts range from $10,000 to over $500,000 depending on injury severity.
Mild temporary gastroparesis typically settles for $10,000 to $50,000.
Severe permanent cases requiring feeding tubes can exceed $500,000.
What is the deadline to file an Ozempic lawsuit claim in 2026?
Most states have a two to four year statute of limitations from when you discovered Ozempic caused your injury.
To maximize settlement inclusion, attorneys recommend filing by June 2026.
Each state has different deadline rules, so consult an attorney promptly.
Do I need medical records to join the Ozempic lawsuit?
Yes, medical records documenting your gastroparesis or stomach paralysis diagnosis are required.
You also need proof of Ozempic use such as prescription records or pharmacy receipts.
Your attorney will help gather these documents during the case intake process.
Can I still file an Ozempic lawsuit if I stopped taking the drug?
Yes, you can file a claim even if you stopped taking Ozempic months or years ago.
The statute of limitations runs from when you discovered the connection between the drug and your injury.
Many successful claimants stopped the medication long before filing their lawsuit.
How long will it take to receive my Ozempic lawsuit payout?
Most plaintiffs will receive settlement payments in late 2026 or early 2027 if settlements are reached.
After settlement approval, payment processing takes 60 to 120 days.
Cases that go to individual trial could take two to three additional years.
Take Action on Your Ozempic Claim
The Ozempic lawsuit in 2026 represents a critical opportunity for injured patients to receive compensation. With settlement talks underway and trials beginning in March, case values are being established right now.
If you experienced gastroparesis, stomach paralysis, or severe vomiting after taking Ozempic, you need to act quickly. Filing by June 2026 ensures you’re included in initial settlement negotiations.
Contact an attorney handling Ozempic cases for a free case evaluation. Gather your medical records and prescription documentation now while details are fresh.
The bellwether trial results in spring 2026 will shape settlement values for years to come. Don’t wait until after these trials when leverage shifts to the defendant.
